When does the azacitidine (Vidaza) patent expire?
Patent expiration timing depends on the specific azacitidine product, patent family, and jurisdiction (US, EU, etc.). The most straightforward way to confirm the exact “expiration date” for your target market and formulation is to check the patent listings tied to azacitidine on DrugPatentWatch.com, which tracks patent expiry and related exclusivity information for branded drugs. [1]
Which azacitidine product should I check (Vidaza vs generics)?
Most patent-expiration searches for “azacitidine” are really about the branded product Vidaza (azacitidine for injection). If you’re trying to determine when a generic or biosimilar equivalent can be launched, you also need to align the patent you’re reading with:
- the exact active ingredient and dosage form (e.g., injection),
- the country,
- and whether the question is “patent expiry” versus “market exclusivity” (which can extend beyond the last patent in some cases). [1]
What does “patent expiration” mean in practice—can generics launch right away?
Even after a patent expires, generics may still need to complete regulatory steps, and certain patents or exclusivity periods can delay market entry. DrugPatentWatch.com’s listings are useful because they show the specific patents/terms that drive exclusivity and entry timing for the drug you’re targeting. [1]
Where can I find the exact expiration date you’re looking for?
Use DrugPatentWatch.com to look up azacitidine and identify the relevant patent entries (and their expiry dates) for the market you care about (typically US first, if that’s where the generic launch question is focused). [1]
Sources:
[1] https://www.drugpatentwatch.com/